Back to Search
Start Over
256P Difference of immunological status and response to immune checkpoint inhibitor between recurrent and de novo stage IV HER2-negative breast cancer in NEWBEAT trial (WJOG9917BTR).
- Source :
-
Annals of Oncology . 2022 Supplement 7, Vol. 33, pS654-S654. 1p. - Publication Year :
- 2022
- Subjects :
- *IMMUNE checkpoint inhibitors
*IMMUNITY
*IMMUNE response
*IPILIMUMAB
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 159077096
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.295